Anavex Life Sciences (AVXL) Assets Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.60% |
| Sep 30, 2025 | 24.62% |
| Jun 30, 2025 | 26.49% |
| Mar 31, 2025 | 30.44% |
| Dec 31, 2024 | 31.60% |
| Sep 30, 2024 | 39.86% |
| Jun 30, 2024 | 45.15% |
| Mar 31, 2024 | 47.71% |
| Dec 31, 2023 | 46.30% |
| Sep 30, 2023 | 42.57% |
| Jun 30, 2023 | 42.57% |
| Mar 31, 2023 | 43.79% |
| Dec 31, 2022 | 39.24% |
| Sep 30, 2022 | 40.55% |
| Jun 30, 2022 | 45.10% |
| Sep 30, 2021 | 76.26% |
| Jun 30, 2020 | 31.71% |
| Mar 31, 2020 | 37.27% |
| Dec 31, 2019 | 34.84% |
| Sep 30, 2019 | 28.06% |
| Jun 30, 2019 | 18.72% |
| Mar 31, 2019 | 14.83% |
| Dec 31, 2018 | 171.10% |
| Sep 30, 2018 | 131.58% |
| Jun 30, 2018 | 498.82% |
| Mar 31, 2018 | 781.33% |
| Dec 31, 2017 | 223.58% |
| Sep 30, 2017 | 362.51% |
| Jun 30, 2017 | 307.61% |
| Sep 30, 2016 | 115.78% |